BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kelly CP, Poxton IR, Shen J, Wilcox MH, Gerding DN, Zhao X, Laterza OF, Railkar R, Guris D, Dorr MB. Effect of Endogenous Clostridioides difficile Toxin Antibodies on Recurrence of C. difficile Infection. Clin Infect Dis 2020;71:81-6. [PMID: 31628838 DOI: 10.1093/cid/ciz809] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Sattler MM, Crews JD. Challenges in the Diagnosis and Management of Recurrent and Severe Clostridioides difficile Infection in Children. J Pediatric Infect Dis Soc 2021;10:S27-33. [PMID: 34791399 DOI: 10.1093/jpids/piab079] [Reference Citation Analysis]
2 Yee KL, Kleijn HJ, Zajic S, Dorr MB, Wrishko RE. A time-to-event analysis of the exposure-response relationship for bezlotoxumab concentrations and CDI recurrence. J Pharmacokinet Pharmacodyn 2020;47:121-30. [PMID: 32048107 DOI: 10.1007/s10928-019-09660-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Giacobbe DR, Dettori S, Di Bella S, Vena A, Granata G, Luzzati R, Petrosillo N, Bassetti M. Bezlotoxumab for Preventing Recurrent Clostridioides difficile Infection: A Narrative Review from Pathophysiology to Clinical Studies. Infect Dis Ther 2020;9:481-94. [PMID: 32632582 DOI: 10.1007/s40121-020-00314-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
4 Ramos-Martínez A, Serrano-Martínez F, Pintos I, Valencia-Alijo Á, Gutiérrez-Rojas Á, Cítores MJ, Ortiz-Balbuena J, Royuela A, Martínez-Ruiz R, Sánchez-Romero I, Asensio Á, Múñez E, Plaza A. Effective definition of low humoral response to Clostridioides difficile infection. Anaerobe 2021;72:102475. [PMID: 34752901 DOI: 10.1016/j.anaerobe.2021.102475] [Reference Citation Analysis]
5 Na'amnih W, Carmeli Y, Asato V, Goren S, Adler A, Cohen D, Muhsen K. Enhanced Humoral Immune Responses against Toxin A and B of Clostridium difficile is Associated with a Milder Disease Manifestation. J Clin Med 2020;9:E3241. [PMID: 33050453 DOI: 10.3390/jcm9103241] [Reference Citation Analysis]
6 Rauseo AM, Olsen MA, Reske KA, Dubberke ER. Strategies to prevent adverse outcomes following Clostridioides difficile infection in the elderly. Expert Rev Anti Infect Ther 2020;18:203-17. [PMID: 31976779 DOI: 10.1080/14787210.2020.1717950] [Reference Citation Analysis]